SCHEMBL29293530

SCHEMBL29293530

O=C(/C(=C/c1ccc(Cl)cc1)CNCc1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
BRAF P15056 2/20 0.46
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
NPSR1 Q6W5P4 2/20 0.43
GLA P06280 1/20 0.43
LMNA P02545 4/20 0.43
MAPT P10636 4/20 0.43
HTT P42858 3/20 0.42
GAA P10253 1/20 0.42
MAOB P27338 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20415219 0.87 SMN1; SMN2 (0.46) ALDH1A1CES2CES1LMNAMAPT
SCHEMBL29073232 0.79 CES2 (0.55) ALDH1A1BRAFCES2CES1NPSR1
SCHEMBL20415317 0.78 LMNA (0.45) ALDH1A1BRAFNPSR1GLALMNA
SCHEMBL20415230 0.77 CES2 (0.53) ALDH1A1BRAFCES2CES1NPSR1
SCHEMBL20415229 0.74 TMEM97 (0.48) ALDH1A1BRAFCES2CES1LMNA
SCHEMBL28925325 0.74 MAPT (0.51) ALDH1A1LMNAMAPTGAAMEN1
SCHEMBL28925326 0.74 MAPT (0.51) ALDH1A1LMNAMAPTGAAMEN1
SCHEMBL2290144 0.74 MAPT (0.62) ALDH1A1CES2CES1LMNAMAPT
SCHEMBL20415256 0.74 EGFR (0.49) ALDH1A1BRAFCES2CES1NPSR1
SCHEMBL28644906 0.72 ALDH1A1 (0.55) ALDH1A1NPSR1LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397652-A2 3-(PHENYL)-2-(AMINOMETHYL)-1-PHENYL-2-PROPEN-1-ONE DERIVATIVES AS INHIBITORS OF THE N-TERMINAL DOMAIN OF THE ANDROGEN RECEPTOR FOR TREATING PROSTATE CANCER The Regents of the University of California (US) 2024-07-10 EP disclosed